Tilray Brands (TLRY) Gains from Sales and Divestitures (2019 - 2025)

Tilray Brands (TLRY) reported Gains from Sales and Divestitures of $33276.0 for Q2 2025, down 72.97% on a YoY basis from $123113.0 in Q2 2024, and down 72.97% quarter-over-quarter from $123113.0 in Q2 2024.

Tilray Brands (TLRY) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends

Tilray Brands has reported Gains from Sales and Divestitures for 7 years, with the latest figure at $33276.0 in Q2 2025.

  • For the quarter ending Q2 2025, Gains from Sales and Divestitures fell 72.97% year-over-year to $33276.0; the trailing twelve-month figure through May 2025 stood at $33276.0 (down 72.97% YoY), and the FY2025 full-year result was $33276.0, down 72.97% from the prior year.
  • Gains from Sales and Divestitures for Q2 2025 stood at $33276.0, down from $123113.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $1.9 million in Q2 2022, with the low at $33276.0 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $684344.2 across 5 years, with a median of $390419.0 in 2023.
  • Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures surged 85.71% — and 2023, when it sank 79.11%.
  • Tilray Brands' Gains from Sales and Divestitures stood at $1.0 million in 2021, then surged by 85.71% to $1.9 million in 2022, then slumped by 79.11% to $390419.0 in 2023, then tumbled by 68.47% to $123113.0 in 2024, then sank by 72.97% to $33276.0 in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $33276.0 (Q2 2025), $123113.0 (Q2 2024), and $390419.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Tilray Brands - - 54.95 Mn

Historic Data

Download Data
DateValue
May 31, 2025 33,276.00
May 31, 2025 33,276.00
May 31, 2024 123,113.00
May 31, 2024 123,113.00
May 31, 2023 390,419.00
May 31, 2023 390,419.00
May 31, 2022 1.87 Mn
May 31, 2022 1.87 Mn
May 31, 2021 1.01 Mn
May 31, 2021 1.01 Mn
Mar 31, 2020 53,125.00
Mar 31, 2020 53,125.00
Dec 31, 2019 122,289.00
Dec 31, 2019 122,289.00
Sep 30, 2019 54,635.00
Sep 30, 2019 54,635.00